features: Trial Updates

Masitinib: the first drug slowing progressive MS pathology

Multiple sclerosis (MS) is a long-life condition that affects the brain and spinal cord resulting in impaired vision, limb movement,…

Read More
The content of VJNeurology is intended for healthcare professionals